Inventor · disambiguated record
Nathaniel Julius Thomas Monck
Also filed as: MONCK NATHANIEL · MONCK NATHANIEL J · MONCK NATHANIEL JULIUS · MONCK NATHANIEL JULIUS THOMAS
13 granted patents·7 pending applications·130 citations·filing 1999–2022
89Inventor score
Files withVERNALIS RES LTD8UCB Biopharma SRL4HOFFMANN LA ROCHE3PADLOCK THERAPEUTICS INC2LATIGO BIOTHERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0193US6706750B1Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal applicationVERNALIS RES LTD·Filed 2000·Granted Mar 16, 2004·68 cites·23 claims
- 0282US6479534B1Indoline derivatives and method of treating obesityHOFFMANN LA ROCHE·Filed 2001·Granted Nov 12, 2002·19 cites·32 claims
- 0371US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 0469US7323466B2Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesityHOFFMANN LA ROCHE·Filed 2006·Granted Jan 29, 2008·1 cites·14 claims
- 0568US6380238B1Indoline derivatives as 5-HT2B and or 5-HTC receptor ligandsVERNALIS RES LTD·Filed 1999·Granted Apr 30, 2002·27 cites·23 claims
- 0661US6531511B12-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2000·Granted Mar 11, 2003·2 cites·27 claims
- 0760US2021299115A1Heteroaryl inhibitors of pad4PADLOCK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0851US2024336574A1Methyl-substituted pyridine and pyridazine compounds, derivatives thereof, and methods of their useLATIGO BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0948US2023271951A1Difluorocyclohexyl derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 1047US6514961B1Azetidinecarboxamide derivatives for the treatment of CNS disordersVERNALIS RES LTD·Filed 2002·Granted Feb 4, 2003·0 cites·29 claims
- 1147US6403574B1Azetidinecarboxamide derivatives for treating CNS disordersVERNALIS RES LTD·Filed 1999·Granted Jun 11, 2002·7 cites·27 claims
- 1246US2024092773A1Dihydro-cyclopenta-isoquinoline sulfonamides derivativesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1345US7547699B2Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesityHOFFMANN LA ROCHE·Filed 2006·Granted Jun 16, 2009·0 cites·17 claims
- 1445US2022073485A1Functionalised Amine Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 1543US7098337B21,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivativesVERNALIS RES LTD·Filed 2003·Granted Aug 29, 2006·0 cites·34 claims
- 1643US2009221582A1Piperazine Derivatives And Their Use In TherapyVERNALIS R & D·Filed 2006·Application pending·0 cites
- 1743US2022242855A1Fused Imidazole Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1836US6262106B1Adamantanecarboximidamide derivatives and their use as NMDA antagonistsVERNALIS RES LTD·Filed 1999·Granted Jul 17, 2001·3 cites·15 claims
- 1934US6831078B1Azetidinecarboxamide derivatives for treating CNS disordersVERNALIS RES LTD·Filed 1999·Granted Dec 14, 2004·2 cites·20 claims
- 2029US9963462B2Sepiapterin reductase inhibitorsQUARTET MEDICINE INC·Filed 2016·Granted May 8, 2018·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Nathaniel Julius Thomas Monck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →